Trials / Unknown
UnknownNCT05861063
The Efficacy and Safety of Dezocine Pretreatment for Pain Relief in Acne Scar Treatment of Fractional CO2 Laser
The Efficacy and Safety of Dezocine Pretreatment for Pain Relief in Acne Scar
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 105 (estimated)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The Efficacy and Safety of Dezocine Pretreatment for Pain Relief in Acne Scar Treatment of Fractional CO2 Laser
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Fractional CO2 laser | All patients were given oral administration of 0.5mg paronosetron hydrochloride and lidocaine cream 1 hour before surgery. After cleaning and disinfection, fractional CO2 laser treatment was given. Among them, the fractional CO2 laser laser (American Medical Laser company) selected relatively constant energy parameters in the treatment |
| DRUG | Dezocine | Desocine injection was injected intravenously half an hour before surgery (10ml normal saline was added for more than 30 seconds) |
Timeline
- Start date
- 2023-02-11
- Primary completion
- 2023-12-30
- Completion
- 2024-12-31
- First posted
- 2023-05-16
- Last updated
- 2023-05-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05861063. Inclusion in this directory is not an endorsement.